Understand MVP reporting requirements, participation options, deadlines, and ASA resources designed to help your practice succeed.
MIPS Value Pathways (MVPs) are a streamlined reporting option within the Merit-based Incentive Payment System (MIPS). MVPs align quality measures, improvement activities, and cost measures around a specialty or clinical focus area. MVP offers a more focused reporting pathway designed to reduce administrative burden while supporting quality improvement and value-based care.
CMS continues to expand value-based payment models across healthcare. Understanding your reporting options is important for maintaining compliance, optimizing reimbursement, and demonstrating the value of anesthesiology care. MVPs are designed to reduce reporting complexity while supporting meaningful quality improvement across the perioperative continuum.
MVPs reduce the number of required quality measures while aligning reporting more closely to specialty practice.
Measures are designed around anesthesiology workflows, patient safety, perioperative care, and outcomes.
Participation helps demonstrate the value of anesthesiology care in evolving payment models.
CMS continues expanding MVP adoption as part of the long-term transition away from Traditional MIPS.
Compare Traditional MIPS vs. Patient Safety and Support of Positive Experiences with Anesthesia MVP at a glance.
6 Quality Measures
General Reporting Framework
Broader Measure Selection
100+ Improvement Activities
4 Quality Measures
Specialty-Focused Reporting
Measures Aligned to Anesthesiology Care
9 Improvement Activities
To successfully report the Anesthesia MVP, participants must:
✔ Report 4 Quality Measures
✔ Attest to 1 Improvement Activity
✔ Submit Promoting Interoperability only if required
➀ Choose your reporting pathway
➁ Select your quality measures
➂ Complete your improvement activity
➃ Submit through AQI NACOR
Participants reporting the Anesthesia MVP through AQI may choose one of the following reporting options.
Timeline
April 1 – November 30, 2026
January 1 – December 31, 2026
CMS timelines to be announced
Measure Description:
The percentage of current smokers who abstain from cigarettes prior to anesthesia on the day of elective surgery or procedure.
Measure Type:
Intermediate Outcome – High Priority
Measure Description:
Percentage of patients, aged 18 years and older, who undergo a procedure under an inhalational general anesthetic, AND who have three or more risk factors for post-operative nausea and vomiting (PONV), who receive combination therapy consisting of at least two prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively.
Measure Type:
Process – High Priority
Measure Description:
Percentage of patients aged 3 through 17 years, who undergo a procedure under general anesthesia in which an inhalational anesthetic is used for maintenance AND who have two or more risk factors for post-operative vomiting (POV), who receive combination therapy consisting of at least two prophylactic pharmacologic antiemetic agents of different classes preoperatively and/or intraoperatively.
Measure Type:
Process – High Priority
Measure Description:
Percentage of patients, aged 18 years and older, undergoing selected surgical procedures that were managed with multimodal pain management.
Measure Type:
Outcome – High Priority
Measure Description:
Percentage of patients, aged 18 and older, who were surveyed on their patient experience and satisfaction with anesthesia care and who reported a positive experience.
Measure Type:
Patient–Reported Outcome – High Priority
Measure Description:
Percentage of patients aged 18 years or older, who undergo an elective procedure lasting 30 minutes or longer requiring inhalational general anesthesia who during the maintenance phase of the anesthetic have a total fresh gas flow less than or equal to 1 L/min (less than or equal to 2 L/min for Sevoflurane).
Measure Type:
Process – High Priority
Measure Description:
Percentage of general anesthesia cases in which mean arterial pressure (MAP) fell below 65 mmHg for cumulative total of 15 minutes or more.
Measure Type:
Intermediate Outcome – High Priority
MVP participants must attest to one approved improvement activity.
CMS defines a subgroup as a subset of clinicians identified by a combination of the group TIN, subgroup identifier, and eligible clinician NPIs. Anesthesiologists participating within multispecialty groups may be eligible to report the anesthesia MVP through subgroup reporting.
Check with your group administrator or CMS for eligibility requirements.
CMS allows eligible anesthesiologists within multispecialty groups to report through subgroup reporting.
Most anesthesiologists qualify for CMS special status designations that may reduce reporting requirements or exempt them from Promoting Interoperability.
MVPs are a streamlined reporting option within the Merit-based Incentive Payment System designed to align quality measures and activities around specialties and clinical conditions.
Yes. Eligible clinicians and groups may choose to report Traditional MIPS, the anesthesia MVP, or the APM Performance Pathway if applicable.
Participants must report four quality measures and attest to one improvement activity.
Most anesthesiologists qualify for special status exemptions and will not need to submit PI data.
The MVP registration period runs from April 1 through November 30 during the performance year.
Eligible clinicians who do not participate may receive a negative Medicare payment adjustment.
ASA's Quality and Regulatory Affairs team and AQI NACOR resources are here to help you understand reporting requirements, participation options, and quality reporting strategies.
Curated by: ASA Department of Quality and Regulatory Affairs
Date of last update: August 19, 2026
You do not have to make a payment at this time, but you can reach out to your practice/group leader to find out when they plan to pay your dues. Email or call the ASA Support team for assistance: (630) 912-2552 or info@asahq.org.
